Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide crossover study of osteocalcin, gonadal axis, and glucose metabolism in men with primary osteoporosis
NL-OMON36967Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of teriparatide in osteoporosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Undercarboxylated osteocalcin, Testosterone concentrations and 3 more. Planned start Nov 2012; status: withdrawn.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON36967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36967.